<?xml version="1.0" encoding="UTF-8"?>
<p id="para250">The same approach is being taken by the New York drug company Regeneron, which says it hopes to start mass producing the most potent antibodies it has identified by mid-April. From there, however, it is still a long road of testing to see if the treatments are safe and can reduce the severity or duration of covid-19.</p>
